Counting the cost: osteoarthritis and workforce productivity with Dr Jason Jin and Prof Ilana Ackerman

Knee osteoarthritis doesn’t just affect joints—it can limit people’s ability to participate fully in work and daily life, shaping their long‑term wellbeing and productivity. In this week's episode of Joint Action we are joined by Jason Jin and Ilana Ackerman to explore how knee osteoarthritis influences workforce participation.

Dr Xingzhong (Jason) Jin is a conjoint research fellow at UNSW and the managing director of Precision Statistics Medtech Consulting. He is a musculoskeletal epidemiologist and health data scientist with a desire to bridge the gap between research and real-world healthcare impacts.

Professor Ilana Ackerman is a Research Professor at the School of Public Health and Preventive Medicine at Monash University and Deputy Director of the Musculoskeletal Health Unit. She is a musculoskeletal epidemiologist and an experienced orthopaedic physiotherapist and has led an important program of clinical and population-based research designed to quantify the personal and societal burden of hip and knee osteoarthritis, forecast trends in arthritis and joint replacement surgery, and evaluate the outcomes of joint replacement. She has also been involved in the development of multiple policy and guideline initiatives for osteoarthritis.

RESOURCES

Journal articles

Loss of Productivity-Adjusted Life-Years in Working-Age Australians Due to Knee Osteoarthritis: A Life-Table Modeling Approach

CONNECT WITH US

Naia Health: https://www.naiahealth.com.au/st-leonards-hub
Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials
Instagram: @ProfDavidHunter
Twitter: @ProfDavidHunter @jointactionorg
Email: hello@jointaction.info
Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(175)

Your osteoarthritis listener questions with Vicky and David

Have you ever wondered whether your painful, stiff joints are just something you have to put up with, or whether there is actually something that can be done? On this week's episode of Joint Action, V...

19 Juli 28min

Choosing shoes for osteoarthritis with A/Prof Kade Paterson

Could the shoes you wear every day be making your knee osteoarthritis better or worse? On this week's episode of Joint Action, Kade Paterson joins Professor David Hunter to explain why footwear matter...

5 Juli 33min

Science without borders: a call to the osteoarthritis community

What happens to global science when funding is cut, borders close, and collaboration is threatened? In this special episode of Joint Action, Professor David Hunter reflects on the proposed changes to ...

21 Juni 17min

When we say “the evidence shows this works,” who was actually included in that evidence? with Prof Christian Barton

When we say a treatment works for knee osteoarthritis, it is worth asking: works for whom? On this week's episode of Joint Action, Professor Christian Barton unpacks the blind spots in osteoarthritis ...

7 Juni 30min

Your osteoarthritis listener questions with David and Vicky

This week on Joint Action, Vicky turns the tables and puts the questions to Professor David Hunter. Three listeners submitted questions spanning gut health, total knee replacement, and the frustrating...

24 Maj 22min

Do you really need surgery for your knee osteoarthritis? with Dr Howard Luks (2021)

The number of surgical procedures for musculoskeletal diseases such as osteoarthritis has increased exponentially over the past years, some of which are unnecessary and leave patients no better off th...

10 Maj 41min

Finding Responders: The Next Phase of OA Biomarkers with Dr Virginia Kraus, Dr Peter Mesenbrink, and Dr Jamie Collins

Can identifying the right patients and the right endpoints transform how we test new osteoarthritis treatments? On this week's episode of Joint Action, we unpack what the FNIH Biomarkers Consortium ha...

26 Apr 29min

Defining the early-stage OA patient: the EsSKOA initiative with Dr Armaghan Mahmoudian

What does it actually mean to have 'early-stage' osteoarthritis, and does catching it sooner really make a difference? On this week's episode of Joint Action, learn more about early-stage knee osteoar...

12 Apr 38min